Key points are not available for this paper at this time.
These results confirmed the clinical safety, performance, and benefits of an innovative active transcutaneous bone conduction implant with a piezoelectric transducer design for patients with CHL, MHL, or SSD.
Ordóñez et al. (2025) studied this question.